Project

Context

Hepatitis B virus (HBV) is a major global public health threat with over 257 million people worldwide.


Read More

Strategy

Stimulating innate signaling and inhibiting viral replication in infected hepatocytes.


Read More

Objectives

Perform a proof of concept clinical trial to evaluate novel immune modulators and their combination to boost...


Read More

Expected Results

Improve the functional cure rate in « CHB » and provide opportunities for finite duration curing therapies...


Read More

Benefits for medical experts

Benefits for patient


Benefits for community

IP-cure-B in numbers

Don't hesitate to contact us!


    CONTACT US